Dendreon Pharmaceuticals LLC



Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of treatments that harness the power of the immune system to extend life. Dendreon’s flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. Nearly 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer. Dendreon is headquartered in Seal Beach, Calif. For more information, please visit  

If you would like to connect with Dendreon Medical Affairs, please contact us by telephone at 1-877-336-3736 option 3, email at, or visit our website

Oncology - Prostate/Testis/Penis/Urethra

Social media

Contact details